percutaneous coronary intervention
Advertisement
Patients receiving maintenance dialysis have a high prevalence of cardiovascular and noncardiovascular comorbidities are ...
In the BASKET-SMALL 2 randomized controlled trial, researchers compared the effect of a drug-coated balloon (DCB) ...
Women have worse health outcomes before and after non-primary percutaneous coronary intervention (PCI) as compared to ...
A study presented at the Transcatheter Cardiovascular Therapeutics (TCT) 2021 Annual Meeting investigated long-term ...
A pooled analysis of randomized trials found that moderate to severe coronary artery calcification (CAC) is associated ...
Data presented at the Transcatheter Cardiovascular Therapeutics (TCT2021) conference and published in the New England ...
Researchers have found that for high bleeding risk individuals, one month of dual antiplatelet therapy (DAPT) after ...
The results of a large number of recent national heart attack studies suggest that patients with cardiogenic shock ...
Risk factors for heart disease put expectant mothers at higher risk for adverse pregnancy outcomes (APO) as well as ...
Patients who experience ST-elevation myocardial infarction (STEMI) after transcatheter aortic valve replacement (TAVR) ...
Deep learning may be able to predict incomplete stent expansion, new research in JACC: Cardiovascular Interventions ...
Statins added to the PCSK9 inhibitor evolocumab were associated with a significant reduction in the risk for developing ...
Bivalirudin yielded similar 30-day mortality rates to heparin following percutaneous coronary intervention (PCI) in ...
Results from a new observational study presented at Transcatheter Cardiovascular Therapeutics (TCT) 2020 showed that ...
Physiologically-guided percutaneous coronary intervention (PCI) lowered the proportion of patients with lower residual ...
New research presented at Transcatheter Cardiovascular Therapeutics (TCT) 2020 showed that coronary intravascular ...
Despite successful percutaneous coronary intervention (PCI), symptomatic patients without residual ischemia improved ...
Percutaneous coronary intervention (PCI) with a bioresorbable vascular scaffold (BVS) in mild non-flow-limiting lesions ...
Crushing prasugrel tablets does not improve TIMI 3 flow in the time just after primary percutaneous coronary ...
Advertisement
630 Madison Ave.
Manalapan, NJ 07726
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.